Page 2466 - Williams Hematology ( PDFDrive )
P. 2466

2437
 2436  Index                                                                                            Index         2437



                    for paroxysmal nocturnal hemoglobinuria,   Glutathione peroxidase, 692t,    β Glycoprotein (GP)I (apolipoprotein H),
                                                                                            2
                         578                                 701t                                 2234, 2235, 2235f, 2236f, 2237
                    for thrombocytopenia in pregnancy,   Glutathione reductase (GR), 692t, 698  Glycoprotein (GP)Ia/IIa. See Integrin α β
                                                                                                                       2 1
                         2010–2011                    Glutathione reductase (GR) deficiency, 698,   Glycoprotein (GP)Ib, 1830–1831f, 1841,
                    for thrombotic thrombocytopenic          700t, 701t, 705, 1020t, 1033         1865, 1866f, 1867f, 1868
                         purpura, 2256                Glutathione S transferase, 701t      Glycoprotein (GP)Ibα (CD42b,c), 1833, 1837,
                    in thymic development, 85         Glutathione synthetase (GS), 692t, 698      1865–1868, 1866f, 1867f, 1877. See
                    for Waldenström macroglobulinemia, 1793  Glutathione synthetase (GS) deficiency, 700t,   also Platelet-type (pseudo-) von
                  Glucose metabolism                         705, 709, 1020t, 1033                Willebrand disease
                    enzymes, 692t, 694–697            Glutathione-5-transferase, 692t      Glycoprotein (GP)Ibβ, 1866–1867
                    pathways, 192–193, 193f, 692–694, 693f  Glutethimide, megaloblastic anemia and,   Glycoprotein (GP)Ib/IX complex,
                  Glucose-6-phosphate, 192, 694              606t                                 1815–1816, 1831, 1834, 1866f,
                  Glucose-6-phosphate dehydrogenase (G6PD)  GLUTs, 192                            1867f, 1877
                    in chronic myelogenous leukemia, 1470  Glycation, aging and, 130–131   Glycoprotein (GP)Ib/IX/V complex (CD42),
                    erythrocyte aging and, 497        Glyceraldehyde-3-phosphate, 694, 695        1839, 1865–1868, 1866f, 1867f,
                    gene for, 697, 702                Glyceraldehyde-3-phosphate dehydrogenase,   1875f, 1881. See also Bernard-
                    in glucose metabolism, 696–697           701t                                 Soulier syndrome
                    structure, 696–697, 697f          Glyceraldehyde phosphate dehydrogenase,   Glycoprotein (GP)Ic/IIa. See Integrin α β
                                                                                                                       6 1
                    variants, 702, 703t                      692t, 695                     Glycoprotein (GP)Ic*/IIa. See Integrin α β
                                                                                                                       5 1
                  Glucose-6-phosphate dehydrogenase (G6PD)   Glycine C-succinyl transferase, 892  Glycoprotein (GP)IIb/IIIa. See Integrin α β
                                                                                                                        IIb 3
                         deficiency                   Glycine N-methyl transferase, 588    Glycoprotein (GP)IIb/IIIa antagonists. See
                    clinical features, 700t, 1020t    Glycocalicin, 1866                          Integrin α β  antagonists
                                                                                                         IIb 3
                    common forms for, 708–709         Glycocalix, 1834                     Glycoprotein (GP)IV (CD36, FAT, SCARB3),
                    course and prognosis, 712         Glycogen storage diseases, 994              1872
                    definition and history, 689–690   Glycogen storage disease type 1b, 1026  deficiency, 2359
                    differential diagnosis, 711       Glycolipids, erythrocyte membrane, 662  in dense bodies, 1843
                    epidemiology, 690, 691f           Glycolipid storage diseases. See Lipid storage   in fatty acid transport, 1872
                    favism in, 692, 707, 709                 diseases                       in monocytes and macrophages, 1052f,
                    genetics, 702                     Glycolysis, 192–193, 193f, 199              1055, 1057t
                    hemolysis/hemolytic anemia in, 707, 708,   in neutrophils, 932, 933t    in platelet adhesion, 1833, 1872
                         708t                           in platelets, 1839–1840             in platelet-leukocyte interactions, 1856
                    laboratory features, 700t, 710–711  Glycolytic (Embden-Meyerhof) pathway,   in platelet membrane, 1836
                    malaria resistance and, 690              692–694, 693f, 932, 933t       thrombosis and, 1856
                    neonatal icterus/jaundice in, 709  Glycophorin A, 2337, 2338f           thrombospondin and, 1845, 1879
                    platelet abnormalities in, 2061   Glycophorin B, 2338f                 Glycoprotein (GP)IV (CD36, FAT, SCARB3)
                    sickle cell disease severity and, 690  Glycophorin C, 668, 670t               deficiency, 2051
                    therapy, 711                      Glycophorins, 663t, 664–665          Glycoprotein (GP)V, 1816, 1868, 1881
                  Glucose phosphate isomerase (GPI)   Glycoprotein (GP)                    Glycoprotein (GP)VI, 1833, 1851, 1857, 1869,
                    activity, 192, 692t                 lymphocyte function-associated,           1879–1880, 1880f, 2293
                    deficiency, 694, 700t, 704               1184–1185, 1185f              Glycoprotein (GP)VI deficiency, 2052
                    in glucose metabolism, 694          in neutrophils, 2358               Glycoprotein (GP)IX (CD42a), 1865, 1866,
                  GLUT1 (SLC2A1), 192                   in newborn, 108                           1866f, 1867f
                  GLUT-3, 1836                          in platelet membrane, 1838f, 1846–1847t,   Glycoprotein (GP)27. See CD151
                  Glutamate carboxypeptidase II (folate      1857–1874, 1858–1859t. See also   Glycosaminoglycans (GAGs), 69, 1936,
                         hydrolase), 586–587                 specific proteins                    1936f, 2027f, 2028
                  Glutamate cysteine ligase (GCL) deficiency,   glycosyl phosphatidylinositol-anchored   Glycosphingolipids, 1956
                         705                                 proteins, 571, 1871           Glycosylation
                  Glutamate cysteine synthetase, 698      immunoglobulin family of cell surface   abnormalities, in congenital
                  Glutamate oxaloacetate transaminase (GOT),   adhesion receptors, 1868–1870      dyserythropoietic anemia type II,
                         193                              integrins. See Integrins                567
                  Glutamine, 192–193, 193f, 199           lectin-containing receptors, 1870–1871  in biosynthesis of von Willebrand factor,
                  γ-Glutamylcysteine synthetase, 688, 692t  leucine-rich repeat glycoprotein      2166
                  γ-D-Glutamyl diaminopimelic acid (DAP),    receptors, 1865–1868           in biosynthesis of VWF, 2167f
                         299, 301f                        scavenger receptors, 1871        Glycosyl phosphatidylinositol-anchored
                  Glutathione (GSH), 694, 698, 706–707    tetraspanins, 1871                      proteins (GPI-APs), 571,
                  Glutathione disulfide (GSSG), 698       tyrosine kinase receptors, 1871–1872    1871








          Kaushansky_index_p2393-2506.indd   2437                                                                       9/21/15   3:22 PM
   2461   2462   2463   2464   2465   2466   2467   2468   2469   2470   2471